TAVR in the Different Types of Aortic Stenosis

Aortic stenosis (AS) is classified according to gradient into high flow and high gradient (D1), low flow-low gradient with reduced ejection fraction (D2), and paradoxical low flow-low gradient with conserved ejection fraction (D3).

Nuevas guías de valvulopatías con actualizaciones clave en TAVI e insuficiencia mitral

D3 AS is characterized by ≥50% ejection fraction, but with systolic volume index ≤35 ml/min.

Post TAVR evolution of D2 and D3 AS, as regards quality of life, has not been thoroughly looked into by the existing studies. 

This study looked at 634 patients, 328 presenting D1, 76 with D2 and 230 with D3 AS.

Mean age was 77, 60% were men and STS was 6.6%, with no significant differences in comorbidities, except in those with D2 AS, who presented higher incidence of cardiac failure, functional class IV, atrial fibrillation, definite pacemaker implantation, higher need of cardio-defibrillator prior TAVR and lower ejection fraction. 

At 30 days, those with D1 AS showed higher mortality (2.5% vs. 0% vs. 0%, p=0.03 for D1, D2 and D3 AS respectively), with no differences in stroke, major bleeding, or dialysis need. The need for definite pacemaker implantation was higher among D2 AS patients.

Read also: Physiologically Significant Obstructions in the Left Main Coronary Artery: Revascularizing vs. Deferring.

After one year followup, there were no significant differences in mortality, stroke, MI, major bleeding, need for pacemaker implantation or readmission. All 3 groups experienced improved functional class and quality of life. D2 AS patients also showed improved ejection fraction. 

Conclusion

Patients with D2 AS experienced significant improvement in ejection fraction and quality of life at 30 days and one year. The need for pacemaker implantation after TAVR was higher than in the other subtypes, while stroke and mortality were lower than expected, which supports the use of TAVR in this high risk group. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Transcatheter Aortic Valve Replacement Improves Quality of Life and Ventricular Function With Low-Flow/Low-Gradient Aortic Stenosis

Reference: Kelley N. Benck , et al. JSCAIhttps://doi.org/10.1016/j.jscai.2023.101266. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...